GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Incanthera PLC (AQSE:INC) » Definitions » Total Debt per Share

Incanthera (AQSE:INC) Total Debt per Share : £0.00 (As of Sep. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Incanthera Total Debt per Share?

£0.00 (As of Sep. 2023)

Total Debt per Share is calculated as total debt divided by Shares Outstanding (EOP). Total debt is calculated as Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Incanthera's Total Debt Per Share for the quarter that ended in Sep. 2023 was £0.00.


Incanthera Total Debt per Share Historical Data

The historical data trend for Incanthera's Total Debt per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Incanthera Total Debt per Share Chart

Incanthera Annual Data
Trend Mar20 Mar21 Mar22 Mar23
Total Debt per Share
- - - -

Incanthera Semi-Annual Data
Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Total Debt per Share Get a 7-Day Free Trial - - - - -

Incanthera Total Debt per Share Calculation

Incanthera's Total Debt Per Share for the fiscal year that ended in Mar. 2023 is calculated as:

Incanthera's Total Debt Per Share for the quarter that ended in Sep. 2023 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Incanthera Total Debt per Share Related Terms

Thank you for viewing the detailed overview of Incanthera's Total Debt per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Incanthera Business Description

Traded in Other Exchanges
N/A
Address
76 King Street, Manchester, GBR, M2 4NH
Incanthera PLC is a specialist dermatology and oncology company focused on transforming cancer treatment by creating environments in which cancer cannot survive. It identifies and develops solutions to current clinical, commercially relevant unmet needs, utilising a new technology. The company's current products are Sol, EP0015, Equin and Duo-C. The company has one segment, namely the development of pharmaceutical products all within the United Kingdom.

Incanthera Headlines